World Journal of Pharmaceutical
and Medical Research

( An ISO 9001:2015 Certified International Journal )

An International Peer Reviewed Journal for Pharmaceutical and Medical Research and Technology
An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)
ISSN 2455-3301
IMPACT FACTOR: 6.842

ICV : 78.6

World Journal of Pharmaceutical and Medical Research (WJPMR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Indian Science Publications , Cosmos Impact Factor , Research Bible, Fuchu, Tokyo. JAPAN , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , International Innovative Journal Impact Factor (IIJIF) , Scientific Journal Impact Factor (SJIF) , Global Impact Factor (In Process) , Digital Online Identifier-Database System (DOI-DS) , Science Library Index, Dubai, United Arab Emirates , Eurasian Scientific Journal Index (ESJI) , International Scientific Indexing, (ISI) UAE , IFSIJ Measure of Journal Quality , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , Scope Database , Academia , 

Abstract

MEASUREMENT OF CHRONIC HEPATITIS B ASSOCIATION WITH QUALITY OF LIFE: A CROSS SECTIONAL STUDY

*Zia Ur Rehman, Muhammad Arshad Mirani and Sidra Aslam

ABSTRACT

Background: The health-related qualities of life (HRQOL) of people, suffering from chronic hepatitis B is (CHB) infection is estimated by some research studies. Aim: The objective of the current studies was to assess the health-related quality of life of a patient at various phases of CHB infection. To estimate the causes of HRQOL were also included in the objective of the study. Methods: This research study was organized in Jinnah Hospital, Lahore from November 2018 to June 2019. All the people interviewed were adult CHB patients and were 520 in total. The interview was taken by means of chronic liver disease Questionnaire (CLDQ), structured Questionnaire and the SF-36 Health Survey Version 2 (SF-36v2). Out of 520 patients interviewed, impaired liver function, hepatocellular carcinoma HCC and cirrhosis were observed in 102, 123 and 139 patients respectively. Moreover, 156 patients were normal. In order to assess the causal factors of HRQOL, multiple linear regression was performed. To check the dissimilarity between each CHB group and population norms regarding SF-6D health preferences Values and SF36v2 scores, T-test was employed. ANOVA was employed to check similarity and difference of mean SF-36v2 scores, CLDQ scores, and SF-6D health preferences among SHB groups. Results: the results indicated the factors connected with poorer HRQOL were younger age, psychological comorbidity, female, anti-viral treatment, advanced stage of CHB illness and bilirubin level. Moreover, as compared to population norm, remarkably lower SF-36v2 scores were noticed in the CHB patients the value of SF6D of CHB patients impaired live function was 0.745, with cirrhosis 0.701, with uncomplicated disorder 0.755 and with HCC was 0.720, on the other hand, 0.787 was value in population norm, which was remarkably lower. Conclusion: In those studies, that are Cost-Effie, the quality-adjusted life years (QALYS) for CHB patients can be passed through results. The results concluded that on HRQOL, CHB infection had a negative impression. Along with CHB disease progression, there observed a progressive decline in health preference values. Keywords: Chronic, Hepatitis, Comorbidity, Health-Related, Life, Quality and Infection.

[Full Text Article]    [Download Certificate]

Powered By WJPMR | All Right Reserved

WJPMR